Javascript must be enabled to continue!
Morphological and morphometric analysis of the effects of intralesional tamoxifen on keloids
View through CrossRef
The aim of this study was to evaluate the effect of intralesional tamoxifen on keloids, particularly on the concentration of fibroblasts, dermal inflammatory infiltrate, and collagen degeneration. A prospective study was carried out to evaluate keloids in 13 patients of both genders pre- and post-treatment with intralesional tamoxifen. Two samples of keloid lesions were obtained by 4-mm punch biopsies during the study: the first at the time of diagnostic confirmation of keloid and the other eight weeks later at the end of intralesional tamoxifen treatment. The biopsy samples were placed in 10% buffered formalin for HE staining and morphological and morphometric study. The degree of collagen fiber reduction and inflammatory infiltration were analyzed. Student’s t-test was used for statistical analysis of the mean number of fibroblasts before and following tamoxifen treatment ( P < 0.05). The degree of collagen fiber reduction and inflammatory infiltration were absent before treatment and present in 100% of cases after treatment, while the mean number of fibroblasts was significantly lower after intralesional tamoxifen treatment ( P < 0.0001). We conclude that intralesional administration of tamoxifen promoted an inflammatory stimulus and collagen fiber reduction as well as a significant reduction in the number of fibroblasts that produce collagen. Impact statement Effective treatment of keloid that is a commonly recurrent dermatosis is very difficult, even after standard treatment. Standard treatment consists of partial resection of the lesion (shaving excision), in addition to local corticosteroid injection. Therefore, there is interest in alternative forms of topical treatment, e.g., selective estrogen receptor modulators, particularly tamoxifen has demonstrated in vitro studies to be a promising drug. Nevertheless, there is scarcity of publications on the effects of intralesional tamoxifen on keloids have been found, leading us to the conception of the present study. In this study, tamoxifen has proven to be an interesting alternative drug for the topical treatment of keloid, allowing us to conclude that the intralesional application of tamoxifen in keloids promotes a variable but ever-present inflammatory stimulus, associated with intense reduction of collagen fiber, in addition to a significant decrease in the number of fibroblasts that produce collagen and are involved in disease maintenance.
Title: Morphological and morphometric analysis of the effects of intralesional tamoxifen on keloids
Description:
The aim of this study was to evaluate the effect of intralesional tamoxifen on keloids, particularly on the concentration of fibroblasts, dermal inflammatory infiltrate, and collagen degeneration.
A prospective study was carried out to evaluate keloids in 13 patients of both genders pre- and post-treatment with intralesional tamoxifen.
Two samples of keloid lesions were obtained by 4-mm punch biopsies during the study: the first at the time of diagnostic confirmation of keloid and the other eight weeks later at the end of intralesional tamoxifen treatment.
The biopsy samples were placed in 10% buffered formalin for HE staining and morphological and morphometric study.
The degree of collagen fiber reduction and inflammatory infiltration were analyzed.
Student’s t-test was used for statistical analysis of the mean number of fibroblasts before and following tamoxifen treatment ( P < 0.
05).
The degree of collagen fiber reduction and inflammatory infiltration were absent before treatment and present in 100% of cases after treatment, while the mean number of fibroblasts was significantly lower after intralesional tamoxifen treatment ( P < 0.
0001).
We conclude that intralesional administration of tamoxifen promoted an inflammatory stimulus and collagen fiber reduction as well as a significant reduction in the number of fibroblasts that produce collagen.
Impact statement Effective treatment of keloid that is a commonly recurrent dermatosis is very difficult, even after standard treatment.
Standard treatment consists of partial resection of the lesion (shaving excision), in addition to local corticosteroid injection.
Therefore, there is interest in alternative forms of topical treatment, e.
g.
, selective estrogen receptor modulators, particularly tamoxifen has demonstrated in vitro studies to be a promising drug.
Nevertheless, there is scarcity of publications on the effects of intralesional tamoxifen on keloids have been found, leading us to the conception of the present study.
In this study, tamoxifen has proven to be an interesting alternative drug for the topical treatment of keloid, allowing us to conclude that the intralesional application of tamoxifen in keloids promotes a variable but ever-present inflammatory stimulus, associated with intense reduction of collagen fiber, in addition to a significant decrease in the number of fibroblasts that produce collagen and are involved in disease maintenance.
Related Results
Risk of Death Due to Breast Cancer in Women Treated with Selective Serotonin Reuptake Inhibitor Antidepressants and Tamoxifen.
Risk of Death Due to Breast Cancer in Women Treated with Selective Serotonin Reuptake Inhibitor Antidepressants and Tamoxifen.
Abstract
Background: Tamoxifen is widely prescribed to women with breast cancer, but is a prodrug converted by cytochrome P450 2D6 (CYP 2D6) to its active metabolite...
ANDROGEN-DEPENDENT DERMOPATHY IN WOMEN WITH KELOID SCARS
ANDROGEN-DEPENDENT DERMOPATHY IN WOMEN WITH KELOID SCARS
Objective: To explore the character of androgen-dependent dermopathy (ADD) in women with keloid scars. Methods: 100 girls and women aged 15-28 years were examined, of whom 47 were...
miR-449a Suppresses Tamoxifen Resistance in Human Breast Cancer Cells by Targeting ADAM22
miR-449a Suppresses Tamoxifen Resistance in Human Breast Cancer Cells by Targeting ADAM22
Background/Aims: Most of estrogen receptor positive breast cancer patients respond well initially to endocrine therapies, but often develop resistance during treatment with selecti...
International Breast Cancer Study Group (IBCSG)
International Breast Cancer Study Group (IBCSG)
This section provides current contact details and a summary of recent or ongoing clinical trials being coordinated by International Breast Cancer Study Group (IBCSG). Clinical tria...
TREATMENT OF KELOIDS AND HYPERTROPHIC SCARS BY COMBINED CRYOTHERAPY AND INTRALESIONAL TRIAMCINOLONE
TREATMENT OF KELOIDS AND HYPERTROPHIC SCARS BY COMBINED CRYOTHERAPY AND INTRALESIONAL TRIAMCINOLONE
Objectives: To evaluate the outcomes of combining cryotherapy and intralesional triamcinolone in the treatment of keloids and hypertrophic scars. Methods: 60 patients (31 males and...
The outcome of postoperative radiation therapy following plastic surgical resection of recurrent ear keloid: a single institution experience
The outcome of postoperative radiation therapy following plastic surgical resection of recurrent ear keloid: a single institution experience
Abstract
Background
Ear keloids are abnormal continuously growing healing process following cutaneous injury. Surgical excision is the standard trea...
Dual targeting of EphA2 and ER restores tamoxifen sensitivity in ER/EphA2-positive breast cancer.
Dual targeting of EphA2 and ER restores tamoxifen sensitivity in ER/EphA2-positive breast cancer.
Abstract
Abstract #3020
Background: Overexpression and altered function of EphA2 receptor tyrosine kinase are critical in the progression of breast ca...
Abstract 1738: Histone deacetylase inhibitor mediated reversal of acquired endocrine therapy resistance in breast cancer cell lines
Abstract 1738: Histone deacetylase inhibitor mediated reversal of acquired endocrine therapy resistance in breast cancer cell lines
Abstract
Although nearly 70% of breast cancers are estrogen receptor (ER) positive, endocrine therapy using the selective ER modulator tamoxifen or the selective ER ...

